These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38270872)

  • 1. Generation of Specific Aptamers.
    Liu S; Suzuki Y; Inui M
    Methods Mol Biol; 2024; 2766():129-137. PubMed ID: 38270872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Specific Aptamers.
    Liu S; Suzuki Y; Inui M
    Methods Mol Biol; 2018; 1868():113-121. PubMed ID: 30244458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].
    Han S; Zhao L; Yang G; Qu F
    Se Pu; 2021 Jul; 39(7):721-729. PubMed ID: 34227370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FluMag-SELEX as an advantageous method for DNA aptamer selection.
    Stoltenburg R; Reinemann C; Strehlitz B
    Anal Bioanal Chem; 2005 Sep; 383(1):83-91. PubMed ID: 16052344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of DNA aptamers specific for small therapeutic peptides using a modified SELEX method.
    Lee J; Ryu M; Bae D; Kim HM; Eyun SI; Bae J; Lee K
    J Microbiol; 2022 Jul; 60(7):659-667. PubMed ID: 35731347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Strand DNA-Like Oligonucleotide Aptamer Against Proprotein Convertase Subtilisin/Kexin 9 Using CE-SELEX: PCSK9 Targeting Selection.
    Sattari R; Palizban A; Khanahmad H
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):475-485. PubMed ID: 32415571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer Selection for Detecting Molecular Target Using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.
    Stewart KD; Tan W; Park JY
    Methods Mol Biol; 2019; 2054():223-241. PubMed ID: 31482459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease.
    Li W; Lan X
    Nucleic Acid Ther; 2015 Aug; 25(4):173-9. PubMed ID: 25993618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA and RNA aptamers: from tools for basic research towards therapeutic applications.
    Ulrich H; Trujillo CA; Nery AA; Alves JM; Majumder P; Resende RR; Martins AH
    Comb Chem High Throughput Screen; 2006 Sep; 9(8):619-32. PubMed ID: 17017882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches.
    Oliveira R; Pinho E; Sousa AL; DeStefano JJ; Azevedo NF; Almeida C
    Trends Biotechnol; 2022 May; 40(5):549-563. PubMed ID: 34756455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Design for the Fixed Primer Regions in an Oligonucleotide Library for SELEX Aptamer Screening.
    Wang B
    Front Chem; 2020; 8():475. PubMed ID: 32582641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.
    Giudice V; Mensitieri F; Izzo V; Filippelli A; Selleri C
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ni-Nitrilotriacetic Acid Affinity SELEX Method for Selection of DNA Aptamers Specific to the N-Cadherin Protein.
    Yang L; Gao T; Li W; Luo Y; Ullah S; Fang X; Cao Y; Pei R
    ACS Comb Sci; 2020 Dec; 22(12):867-872. PubMed ID: 33146506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Lambda-Exonuclease SELEX Method for Generating Aptamers to Bacterial Targets.
    Gowland R; Gowers DM
    Methods Mol Biol; 2023; 2633():145-161. PubMed ID: 36853463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical science.
    Kong HY; Byun J
    Biomol Ther (Seoul); 2013 Nov; 21(6):423-34. PubMed ID: 24404332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.